moderna-already-got-400-million-for-a-covid-vaccine-that-isnt-available Photo

Moderna, one of the companies working on a treatment for Covid-19, said Wednesday that it’s on track to finish enrollment for a phase 3 study of its vaccine by the end of September.

New York (CNN Business)Moderna, one of the companies working on a treatment for Covid-19, said Wednesday that it’s on track to finish enrollment for a phase 3 study of its vaccine by the end of September.

The biotech, which has received funding from the United States’ Operation Warp Speed program, also said it had about $400 million of customer deposits for a potential supply of its mRNA-1273 vaccine.

Moderna made the announcement in its earnings release Wednesday morning. The company posted a loss that was smaller than expected but revenue that topped forecasts.

Top Tweets About The Story

Top News Stories